Viewing Study NCT07454668


Ignite Creation Date: 2026-03-26 @ 3:15 PM
Ignite Modification Date: 2026-07-07 @ 7:26 PM
Study NCT ID: NCT07454668
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-06
First Post: 2026-02-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases
Sponsor: Baptist Health South Florida
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None HER2-positive Breast Cancer View
None Brain Metastases View
None Cancer View
None Cancer Metastatic View
Keywords: